Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Central nervous system tumors include a variety of benign and malignant types, mainly affecting adults and children. The disease is complex, and treatment plans are diverse, involving surgery, radiotherapy, chemotherapy, and emerging immune reconstruction cell therapy. Missing timely treatment may lead to severe neurological loss and life-threatening risks.
Immune reconstruction cell therapy activates the patient’s own immune system, enhancing the recognition and clearance of tumor cells and improving treatment outcomes. This therapy combines targeting and systemic action, can improve neurological function, and extend patient survival.
① Activates immune cells to enhance anti-tumor ability
② Reconstructs the immune microenvironment to inhibit tumor growth
③ Enhances overall immune status, reducing recurrence risk
④ Works synergistically with other therapies for greater efficacy
In clinical treatment, tumor patients undergoing surgery, radiotherapy, or chemotherapy often face immune dysfunction, increased infection risk, and slow recovery. To help patients better sustain treatment, improve tolerance, and enhance quality of life, phased immune reconstruction programs must be scientifically tailored for different treatment cycles.
● Short-term plan: Rapidly boost immunity through immune cell reinfusion to enhance anti-tumor effects.
● Mid-term plan: Reduce side effects of conventional treatments, promote recovery, and ensure completion of standard therapy.
● Long-term plan: Comprehensive improvement of immunity through immune cell reconstruction, gut immunity restoration, elemental immunity rebuilding, and immune nutritional support, thereby improving quality of life and prolonging survival.
1. Surgical Treatment
Surgery is the cornerstone of treatment for most central nervous system tumors. Microsurgical techniques aim to maximize tumor resection while relieving intracranial pressure and neural compression. With the development of neuronavigation and intraoperative monitoring, surgical safety and precision have significantly improved.
2. Radiotherapy
Radiotherapy targets tumors that cannot be completely resected or are malignant, effectively killing residual tumor cells and preventing recurrence. Modern radiotherapy techniques such as stereotactic radiotherapy (SRT) deliver high-dose precise irradiation, minimizing damage to normal tissues.
3. Chemotherapy
Chemotherapy is commonly used for malignant central nervous system tumors, particularly glioblastoma multiforme. Since chemotherapy drugs penetrate the blood-brain barrier to a limited extent, combining them with immunotherapy can improve overall efficacy.
4. Minimally Invasive Techniques
With technological advances, minimally invasive surgery, endoscope-assisted resection, and stereotactic radiosurgery have become important complementary approaches.
Minimally invasive surgery reduces incision trauma and shortens recovery time.
Endoscope-assisted techniques improve visualization and enhance surgical safety.
Stereotactic radiosurgery provides precise, non-invasive treatment, suitable for certain benign tumors and recurrent patients.
5. Targeted Therapy and Gene Therapy
Some patients benefit from targeted drugs directed at tumor-specific gene mutations. Gene therapy aims to repair or replace abnormal genes and holds broad future potential in clinical applications.
6. Comprehensive Treatment Plans
Combining immune reconstruction cell therapy with surgery, radiotherapy, and chemotherapy as part of a multidisciplinary plan provides personalized treatment tailored to different tumor types and stages, maximizing therapeutic effect.
Treatment of central nervous system tumors requires multimodal approaches, with immune reconstruction cell therapy offering new hope for patients. Experts at United Life International Medical Center emphasize that early diagnosis, individualized treatment, and integration of emerging therapies are key to improving survival rates and quality of life.
